HCP, Inc. (HCP). Below are some highlights from the above linked analysis:
Company Description: Health Care Property Investors, Inc. is a California based equity-oriented real estate investment trust that has direct or joint venture investments in health care-related facilities across the U.S.
Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description:
1. Avg. High Yield Price
2. 20-Year DCF Price
3. Avg. P/E Price
4. Graham Number
HCP is trading at a discount to only 3.) above. The stock is trading at a 9.7% discount to its calculated fair value of $49.04. HCP earned a Star in this section since it is trading at a fair value.
Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description:
1. Free Cash Flow Payout
2. Debt To Total Capital
3. Key Metrics
4. Dividend Growth Rate
5. Years of Div. Growth
6. Rolling 4-yr Div. > 15%
HCP earned one Star in this section for 3.) above. HCP earned a Star for having an acceptable score in at least two of the four Key Metrics measured. The company has paid a cash dividend to shareholders every year since 1985 and has increased its dividend payments for 29 consecutive years.
Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description:
1. NPV MMA Diff.
2. Years to > MMA
HCP earned a Star in this section for its NPV MMA Diff. of the $1,100. This amount is in excess of the $600 target I look for in a stock that has increased dividends as long as HCP has. The stock's current yield of 4.92% exceeds the 2.98% estimated 20-year average MMA rate.
Memberships and Peers: HCP is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers™ Index and a Dividend Champion. The company's peer group includes: Health Care REIT, Inc. (HCN) with a 4.2% yield, Omega Healthcare Investors Inc. (OHI) with a 5.5% yield and National Health Investors Inc. (NHI) with a 4.6% yield.
Conclusion: HCP earned one Star in the Fair Value section, earned one Star in the Dividend Analytical Data section and earned one Star in the Dividend Income vs. MMA section for a total of three Stars. This quantitatively ranks HCP as a 3-Star Hold stock.
Using my D4L-PreScreen.xls model, I determined the share price would need to increase to $55.51 before HCP's NPV MMA Differential decreased to the $600 minimum that I look for in a stock with 29 years of consecutive dividend increases. At that price the stock would yield 3.9%.
Resetting the D4L-PreScreen.xls model and solving for the dividend growth rate needed to generate the target $500 NPV MMA Differential, the calculated rate is 0.2%. This dividend growth rate is lower than the 2.7% used in this analysis, thus providing a margin of safety. HCP has a risk rating of 1.25 which classifies it as a Low risk stock.
HCP's a real estate investment trust (REIT) with a diversified portfolio of health care-related properties. In the long run, HCP should benefit from increased healthcare spending and an aging population. In addition, the company has the potential to continue growth through strategic acquisitions, tie-ups and other investments, in spite of intense competition within the industry.
In early November, the REIT announced third-quarter 2014 adjusted funds from operations (FFO) per share of $0.75, down $0.04 from last year's third-quarter. Despite a rise in revenues, the lower FFO was a result of higher expenses. Concurrent with its third-quarter earnings release, HCP raised its full-year FFO 2014 outlook to $2.98 – $3.04 per share. This reflects an increase from the prior range of $2.97 – $3.03 per share for adjusted FFO.
The company's debt to total capital of 46% is slightly above my maximum of 45%. Its free cash flow payout of 199% is well above my desired level and is high even for a REIT considering they are required to payout 90% of their earnings as a dividends. The stock is currently trading at a 9.7% discount to my calculated fair value of $49.04. I plan to keep an eye on the free cash flow payout and look for opportunities to add to my position in HCP.
Disclaimer: Material presented here is for informational purposes only. The above quantitative stock analysis, including the Star rating, is mechanically calculated and is based on historical information. The analysis assumes the stock will perform in the future as it has in the past. This is generally never true. Before buying or selling any stock you should do your own research and reach your own conclusion. See my Disclaimer for more information.
Full Disclosure: At the time of this writing, I was long in HCP (2.5% of my Dividend Growth Portfolio). See a list of all my dividend growth holdings here.
- Dividend Stock Analysis: Windows Is Still A Central Part Of Microsoft's Business
- Chevron Corporation: Is Now The Right Time To Add To Your Position?
- Realty Income Corp. Dividend Stock Analysis
- Wal-Mart Is Facing Fierce Competition
- Occidental Petroleum Corporation, 4-Star Stock With A High Free Cash Flow Payout
- More Stock Analysis
Tags: HCP, HCN, OHI, NHI,
Popular Posts - Last 7 days
In an utopian world, the perfect dividend stock would be one that is both high-yield and provide a high dividend growth rate. Its share pri...
Linked here is a detailed quantitative analysis of Apple Inc. (AAPL). Below are some highlights from the above linked analysis: Company D...
As mentioned in previous articles, I love inspirational (and other) quotes . I see quotes as a portal to someone’s inner self. They reveal m...
Linked here is a detailed quantitative analysis of The Clorox Company (CLX). Below are some highlights from the above linked analysis: Co...
Each weekend I highlight any notable articles that I came across over the past week. Though I may not always agree with each of the articles...
Dividend sustainability is paramount for the high-yield investor. Having a stock cut its dividend could potentially crush their income. A hi...
I couldn't begin to estimate how many different stocks are traded around the world on the various exchanges. Like everything else, there...
Charlie Munger, Warren Buffett's friend and partner, is quite an investor in his own right. Munger is vice chairman of Berkshire Hathawa...
Presented below are are my Dividend Growth Stocks portfolio holdings. This is not a recommendation to buy these securities. I have classifi...
Linked here is a detailed quantitative analysis of Microsoft Corporation (MSFT). Below are some highlights from the above linked analysis: ...